Apogee Therapeutics
APGE
Last Price
52 Week Range
$26.20 - $84.56
Next Earnings Date
May 11 2026 (Estimate)
Next Earnings Date
May 11 2026 (Est.)
Last Price
Apogee Therapeutics SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Apogee Therapeutics, Inc. | 8-K | March 25, 2026 | |
Apogee Therapeutics, Inc. | 8-K | March 23, 2026 | |
Apogee Therapeutics, Inc. | 8-K | March 2, 2026 | |
Apogee Therapeutics, Inc. | 10-K | March 2, 2026 | |
Apogee Therapeutics, Inc. | 8-K | January 6, 2026 | |
Apogee Therapeutics, Inc. | 8-K | November 10, 2025 | |
Apogee Therapeutics, Inc. | 10-Q | November 10, 2025 | |
Apogee Therapeutics, Inc. | 8-K | October 10, 2025 | |
Apogee Therapeutics, Inc. | 8-K | August 11, 2025 | |
Apogee Therapeutics, Inc. | 10-Q | August 11, 2025 | |
Apogee Therapeutics, Inc. | 8-K | July 7, 2025 | |
Apogee Therapeutics, Inc. | 8-K | June 23, 2025 | |
Apogee Therapeutics, Inc. | 10-Q | May 12, 2025 | |
Apogee Therapeutics, Inc. | 8-K | May 12, 2025 | |
Apogee Therapeutics, Inc. | DEFA14A | April 29, 2025 | |
Apogee Therapeutics, Inc. | DEF 14A | April 29, 2025 | |
Apogee Therapeutics, Inc. | ARS | April 29, 2025 | |
Apogee Therapeutics, Inc. | 8-K | March 11, 2025 | |
Apogee Therapeutics, Inc. | 8-K | March 3, 2025 | |
Apogee Therapeutics, Inc. | 10-K | March 3, 2025 | |
Apogee Therapeutics, Inc. | 8-K | February 3, 2025 | |
Apogee Therapeutics, Inc. | 8-K | December 10, 2024 | |
Apogee Therapeutics, Inc. | 8-K | December 2, 2024 | |
Apogee Therapeutics, Inc. | 8-K | November 12, 2024 | |
Apogee Therapeutics, Inc. | 10-Q | November 12, 2024 | |
Apogee Therapeutics, Inc. | 8-K | October 24, 2024 | |
Apogee Therapeutics, Inc. | 8-K | August 19, 2024 | |
Apogee Therapeutics, Inc. | 8-K | August 12, 2024 | |
Apogee Therapeutics, Inc. | S3ASR | August 12, 2024 | |
Apogee Therapeutics, Inc. | 10-Q | August 12, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.